Inhibitor of IGF1 receptor alleviates the inflammation process in the diabetic kidney mouse model without activating SOCS2
Jiayu Li,1 Rong Dong,2 Jiali Yu,2 Sun Yi,2 Jingjing Da,2 Fuxun Yu,3 Yan Zha2 1Guizhou University School of Medicine, Guizhou University, 2Department of Nephrology, Guizhou Provincial People’s Hospital, 3Department of Central Laboratory, Guizhou Provincial People’s Hospit...
Main Authors: | Li J, Dong R, Yu J, Yi S, Da J, Yu F, Zha Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-09-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/inhibitor-of-igf1-receptor-alleviates-the-inflammation-process-in-the--peer-reviewed-article-DDDT |
Similar Items
-
Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
by: Stefanie de Groot, et al.
Published: (2020-11-01) -
IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer
by: Yann Neuzillet, et al.
Published: (2017-09-01) -
Therapeutic Targeting of the IGF Axis
by: Eliot Osher, et al.
Published: (2019-08-01) -
Insulin-Like Growth Factor-1 (IGF-1) and Its Monitoring in Medical Diagnostic and in Sports
by: Julian Bailes, et al.
Published: (2021-02-01) -
The Insulin/IGF system in colorectal cancer development and resistance to therapy
by: Paolo Giovanni Vigneri, et al.
Published: (2015-10-01)